Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

DOID EFO MESH PheWeb

CD2_BENIGN_LIPO_SKIN_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D17.3&

Hospital discharge: ICD-9 $!$

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 D17.3&

Cause of death: ICD-9 $!$

Cause of death: ICD-8 $!$

158

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

158

Check minimum number of events None

158

Include endpoints None

158

CD2_BENIGN_LIPO_SKIN_NOS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D17

Name in latin Neoplasma benignum lipomatosum cutis sive textus subcutanei locis aliis sive non specificatis

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

All

Female

Male

Number of individuals

151

Unadjusted prevalence (%)

0.05

0.06

0.04

Mean age at first event (years)

53.04

51.32

56.21

?

Follow-up

Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019.

Absolute risk

Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details.

Hazard Ratio (HR) and 95% Confidence Interval (CI)

Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1).

Number of individuals (N)

Number of individuals having the current endpoint and died during the follow-up time.
Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_LIPO_SKIN_NOS – Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
after Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

↥